Join us at:
4th Annual Biomarker & Companion Diagnostics Conference
Metabolon is excited to be participating in the 4th Annual Biomarker & Companion Diagnostics Conference in London.
The combination of metabolomics and biomarker discovery is increasingly used in drug discovery and development, which can be uniquely applied to personalized medicine and companion diagnostics.
Join Business Development Director, Kieran Jones, who will be participating in the discussions and booking meetings to discuss how Metabolon’s metabolomics solutions can support your biomarker-driven drug development with the industry’s broadest and most precise metabolite discovery platform.
Recent Comments